YY/T 1823-2022 English PDFUS$399.00 ยท In stock
Delivery: <= 4 days. True-PDF full-copy in English will be manually translated and delivered via email. YY/T 1823-2022: Cardiovascular implants - Standard test method for nickel ion release of nickel-titanium alloy Status: Valid
Basic dataStandard ID: YY/T 1823-2022 (YY/T1823-2022)Description (Translated English): Cardiovascular implants - Standard test method for nickel ion release of nickel-titanium alloy Sector / Industry: Medical Device & Pharmaceutical Industry Standard (Recommended) Classification of Chinese Standard: C35 Word Count Estimation: 19,168 Issuing agency(ies): State Drug Administration YY/T 1823-2022: Cardiovascular implants - Standard test method for nickel ion release of nickel-titanium alloy---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order. Cardiovascular implants - Standard test method for nickel ion release of nickel-titanium alloy ICS 11.040.40 CCSC35 People's Republic of China Pharmaceutical Industry Standard Cardiovascular Implants Nitinol alloy nickel ion release test method Published on 2022-05-18 2023-06-01 Implementation Released by the State Drug Administration directory Preface III Introduction IV 1 Scope 1 2 Normative references 1 3 Terms and Definitions 1 4 Test method 2 5 Result calculation 4 6 Report 5 Appendix A (Informative) In Vitro Determination of Nickel Ion AL6 Reference 11 forewordThis document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for Standardization Work Part 1.Structure and Drafting Rules of Standardization Documents" drafted. Please note that some content of this document may be patented. The issuing agency of this document assumes no responsibility for identifying patents. This document is proposed by the State Drug Administration. This document is approved by the National Technical Committee for Standardization of Surgical Implants and Orthopedic Devices Subcommittee on Cardiovascular Implants (SAC/ TC110/SC2) focal point. This document is drafted by. Lifetech Technology (Shenzhen) Co., Ltd., Shenzhen Leading Medical Service Co., Ltd., Shenzhen Medical Device Testing Center, Jiangyin Farsenpeier New Material Technology Co., Ltd., National Standard (Beijing) Inspection and Certification Co., Ltd., Tianjin Medical Device Quality Supervision inspection center. The main drafters of this document. Liu Yanwen, Muying, Li Anning, Yang Han, Peng Jun, Wang Lingling, Chen Qingfu, Zhang Wenmei, Fan Zhigang, Ma Jinzhu, Duan Qingjiao.IntroductionNickel ion is a heavy metal ion. Excessive intake of nickel can cause central circulation and respiratory disorders, and cause water in the heart muscle, brain, lung and kidney. Swelling, bleeding or degeneration may increase the incidence of leukemia and cancer. Studies have shown that nickel has immunotoxicity, especially for those allergic to nickel. crowd. In the adult population, nickel allergy is estimated to occur in 10% of women (17%) higher than men (3%) [22]. Therefore, after Nitinol cardiovascular implants are implanted in the human body, the release rate and release amount of Ni ions from Nitinol alloys are used to evaluate their clinical use. Important content for security. However, due to the long time, high cost, and low accuracy of the test results in vivo (the body's interference with the test results) In the preclinical evaluation stage, it is advisable to establish an in vitro nickel ion release model to form an in vitro test for nickel ion release evaluation. method. At present, there is no similar test standard for in vitro release of nickel ions in China. The formulation of this document will fill this gap and establish Unified test method for nickel ion release in vitro from nitinol cardiovascular implants. If the pitting test results do not meet the expected defined acceptance criteria If the surface finishing process of the device does not have a good history of clinical use [8], it is recommended to use this document to evaluate the nickel ion content through the in vitro test. The risk of nickel ion release can be estimated to better ensure the safety of related products in clinical use. Cardiovascular Implants Nitinol alloy nickel ion release test method1 ScopeThis document specifies a test method for the in vitro release of nickel ions from nickel-titanium alloy cardiovascular implants. An example of the calculation of the maximum allowable limit. This document applies to nickel-titanium alloy cardiovascular implants, including vascular stents, cardiac occluders, vena cava filters, heart valves, etc.2 Normative referencesThe contents of the following documents constitute essential provisions of this document through normative references in the text. Among them, dated citations documents, only the version corresponding to that date applies to this document; for undated references, the latest edition (including all amendments) applies to this document. GB/T 6682 Analysis Laboratory Water Specifications and Test Methods GB/T 16886.1-2011 Biological Evaluation of Medical Devices Part 1.Evaluation and Testing in Risk Management Process GB/T 16886.17-2005 Biological Evaluation of Medical Devices Part 17.Establishment of Allowable Limits for Leachables Chinese Pharmacopoeia (four volumes of the 2020 edition)3 Terms and DefinitionsThe terms and definitions defined in GB/T 16886.17-2005 and the following apply to this document. 3.1 detectionlimit detectionlimit Under the optimal test conditions, measure no less than 7 blank sample solutions to continuously measure 3 times the standard of the response value of the blank sample solution The concentration of the element to be measured corresponding to the deviation (3SD). 3.2 quantitativelimit Under the best test conditions, measure no less than 7 blank sample solutions to continuously measure 10 times the standard deviation of the response value of the blank solution. The concentration of the element to be tested corresponding to the difference (10SD). 3.3 simulated-use extraction simulated-use extraction The test material or sample is extracted with a suitable medium under conditions simulating the use of the product, the purpose of which is to evaluate the Potential hazards to the patient or user during bed use. Note. The simulated use of leaching should consider all possible conditions such as the tissue contacted by the device, contact temperature and contact time, and assume the most severe conditions of use. 3.4 Sample test area testareaofsample The surface area of the Nitinol portion of the device that comes into contact with the human body. ......Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of YY/T 1823-2022_English be delivered?Answer: Upon your order, we will start to translate YY/T 1823-2022_English as soon as possible, and keep you informed of the progress. The lead time is typically 2 ~ 4 working days. The lengthier the document the longer the lead time.Question 2: Can I share the purchased PDF of YY/T 1823-2022_English with my colleagues?Answer: Yes. The purchased PDF of YY/T 1823-2022_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to Sales@ChineseStandard.net. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay. |
